查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2041754

支氣管鏡市場預測至2034年－按產品類型、組件應用、應用領域、最終用戶和地區分類的全球分析

Bronchoscopy Market Forecasts to 2034 - Global Analysis By Product Type (Bronchoscopes), By Component (Imaging Systems, Accessories and Other Components) Usage, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球支氣管鏡市場規模將達到 35 億美元，並在預測期內以 9.9% 的複合年成長率成長，到 2034 年將達到 76 億美元。

支氣管鏡檢查是一種可以直接觀察和評估肺部及氣道的醫療程序。支氣管鏡是一種細長、柔軟的管狀醫療設備，經口或鼻插入氣道，直至咽喉。支氣管鏡檢查能夠直接觀察呼吸系統，有助於治療和診斷各種肺部疾病。

根據國際呼吸學會論壇（FORIS）2022年的報告，慢性阻塞性肺病（COPD）患者人數估計約2億，氣喘患者人數約2.62億人。鑑於呼吸系統疾病的高發生率和癌症病例的不斷增加，預計用於診斷這些疾病的支氣管鏡檢查需求將會增加，最終推動市場發展。

呼吸系統和肺部疾病負擔加重

肺癌、慢性阻塞性肺病（COPD）、氣喘、肺炎和結核病等呼吸系統疾病的日益流行，推動了對支氣管鏡等診斷程序的需求成長。此外，由於這些疾病通常需要準確的分期和診斷，支氣管鏡檢查對於獲取組織樣本和評估氣道以做出正確診斷至關重要。在肺部疾病領域，患者對微創治療方式的偏好，使得支氣管鏡檢查成為開胸手術的替代方案，推動了市場成長。

生產成本高且實施難度高

間接成本上升可能導致檢查費和自付費用增加，以彌補這些支出。這可能會增加患者、保險公司或政府醫療保健項目的成本，從而對醫療保健預算以及支付方和患者的負擔能力產生負面影響。間接成本過高的地區可能出現服務分配不均的情況，例如提供支氣管鏡檢查的醫院較少。這可能導致先進的診斷和治療性支氣管鏡檢查服務的可及性存在差異，從而影響患者的治療。

支氣管鏡技術的進步

先進的支氣管鏡技術能夠對氣道進行多種治療操作，包括消融術、支氣管熱成形術、切片檢查、支架置入術、腫瘤切除術和去除異物。這些功能增強了支氣管鏡的治療效用，使其應用範圍超越了診斷。此外，諸如虛擬支氣管鏡、電磁導航支氣管鏡（ENB）和支氣管內超音波（EBUS）等尖端成像技術能夠對氣道及其周圍結構進行全面、即時的成像，從而推動市場成長。

併發症風險

醫療機構和醫護人員可能因支氣管鏡檢查併發症而面臨法律和責任問題。醫護人員嚴格遵守臨床標準和規範對於減輕這些困難並預防潛在訴訟至關重要。這進一步增加了執行此類手術的複雜性和謹慎性。如果出現問題，可能會引起監管機構的關注，並導致實施更嚴格的支氣管鏡檢查政策和品管流程。為了維持合規性，醫療機構必須證明其遵守嚴格的指南，這可能會影響營運效率、資源利用率，並可能阻礙市場成長。

新型冠狀病毒（COVID-19）的影響

由於支氣管鏡檢查會產生氣溶膠，醫護人員在檢查過程中面臨更高的感染風險。因此，目前正在採取措施降低病毒傳播的可能性，例如使用一次性支氣管鏡、術前進行PCR檢測以及佩戴個人防護工具。這些臨床實踐的改變正在影響支氣管鏡檢查服務和設備的供需。然而，鑑於支氣管鏡檢查存在顯著的感染風險，其在診斷COVID-19方面的效用仍有爭議。需要進一步研究以確定疫情對支氣管鏡檢查市場的長期影響。

在預測期內，支氣管鏡檢查部分預計將是最大的部分。

支氣管鏡市場預計將迎來高速成長。這是因為先進的支氣管鏡能夠進行多種治療操作，包括切片檢查、切除、治療性介入、去除異物和支架置入。支氣管鏡兼具治療和診斷功能，其多功能性推動了市場需求。製造商之間為研發和銷售更先進的支氣管鏡而展開的激烈競爭，也促進了產業創新。各公司紛紛投資於新的配件、功能和技術，以期透過改進和差異化產品來擴大市場佔有率。

在預測期內，支氣管診斷領域預計將呈現最高的複合年成長率。

預計在預測期內，支氣管診斷領域將呈現最高的複合年成長率。這是因為該領域提供個人化和標靶治療，例如手術、化療、放射線治療或標靶治療，幫助醫生確定肺部疾病的階段、類型和特徵。醫療專業人員越來越依賴支氣管鏡檢查來準確快速診斷呼吸系統疾病，這推動了市場對支氣管診斷程序和支氣管鏡檢查的需求。

市佔率最大的地區：

由於北美地區癌症發生率上升以及微創手術日益普及等因素，預計北美將在預測期內佔據最大的市場佔有率。此外，醫學影像技術的顯著進步使得標靶癌症治療成為可能，介入性腫瘤學家可以將影像引導治療納入日常臨床實踐，這也推動了市場成長。另外，根據加拿大癌症協會2022年11月發布的數據，預計當年將有233,900名加拿大人被診斷出罹患癌症。發病率的上升主要是由於加拿大人口老化和成長，凸顯了癌症預防的必要性。

複合年成長率最高的地區：

預計亞太地區在預測期內將維持最高的複合年成長率，這主要得益於各國政府加大癌症治療投入的舉措、有利於尖端技術和產品商業化及開發的法規環境、不斷成長的醫療保健支出，以及中國、日本和印度等國研究中心的擴建。此外，多個國家前景良好的報銷方案和法律規範也正在加速支氣管鏡檢查的普及，並推動該地區市場成長。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章：執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球支氣管鏡市場：依產品類型分類

  • 支氣管鏡檢查
    • 死板的
    • 靈活的
    • 支氣管內超音波（EBUS）

第6章 全球支氣管鏡市場：依組件分類

  • 影像系統
    • 光源
    • 視訊處理器
    • 相機鏡頭
    • 無線顯示器和監視器
  • 配件
    • 喉舌
    • 清潔刷
    • 切片檢查閥
    • 經支氣管細針抽吸
    • 細胞學刷
    • 切片檢查鉗
    • 其他配件
  • 其他規則

第7章：全球支氣管鏡市場：依用途分類

  • 拋棄式的
  • 可重複使用的

第8章 全球支氣管鏡市場：依應用分類

  • 支氣管治療
  • 支氣管診斷

第9章 全球支氣管鏡市場：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 其他最終用戶

第10章 全球支氣管鏡市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第11章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章：公司簡介

  • Boston Scientific
  • Cook Medical
  • Ethicon.Inc
  • Fujifilm Holdings Corporation
  • Olympus Corporation
  • Richard Wolf GmbH
  • Roper Technologies
  • Teleflex Incorporated.
  • Medtronic
  • Lymol Medical
  • Hoya Corporation
  • Karl Storz
  • AMBU A/S
  • Conmed Corporation
  • Broncus Medical Inc.
  • Novatech SA
  • Pentax Medical
Product Code: SMRC24818

According to Stratistics MRC, the Global Bronchoscopy Market is accounted for $3.5 billion in 2026 and is expected to reach $7.6 billion by 2034 growing at a CAGR of 9.9% during the forecast period. A bronchoscopy is a medical treatment that allows one to see and assess the lungs and airways. Bronchoscope is a device, which is a thin, flexible tube that is inserted into the mouth or nose, down the throat, and into the airways. Direct vision of the respiratory system is made possible by bronchoscopy, which enables treatment and diagnostic procedures for a range of lung diseases.

According to the Forum of International Respiratory Societies report 2022, approximately 200 million people are estimated to have COPD, and 262 million are affected by Asthma. With such a high prevalence of respiratory disease and a rise in cancer cases, the demand for bronchoscopes is expected to increase to diagnose this disease, eventually driving the market.

Market Dynamics:

Driver:

Growing burden of respiratory diseases and lung

There is a growing need for diagnostic procedures like bronchoscopies due to the rising prevalence of respiratory disorders such lung cancer, chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and TB. In addition, the bronchoscopy is essential for collecting tissue samples and assessing the airways in order to provide an appropriate diagnosis since these illnesses frequently need for precise staging and diagnosis. When it comes to lung-related illnesses, bronchoscopy presents an option to open operations as patient preferences move toward less intrusive methods boosting the market growth.

Restraint:

High production costs and difficulty in application

Elevated overhead costs might result in higher prices for procedures or levies to pay for these outlays. This may have an adverse effect on healthcare budgets and affordability for payers and patients equally by raising expenses for patients, insurance companies, or government healthcare programs. There may be an unequal distribution of bronchoscopy services, with fewer hospitals providing these procedures, in areas where overhead costs are too high. Patient treatment may be impacted by differences in availability to sophisticated diagnostic and therapeutic bronchoscopy services as a result of this.

Opportunity:

Technological advancements in bronchoscopy

Various therapeutic treatments within the airways, including ablation methods, bronchial thermoplasty, biopsies, stent placements, tumor removal, and the removal of foreign materials, are made possible by advanced bronchoscope technology. These features raise the bronchoscopy's utility for therapeutic applications and broaden its application beyond diagnosis. Furthermore, the comprehensive, real-time imaging of the airways and surrounding structures is made possible by virtual bronchoscopy and modern imaging modalities including electromagnetic navigation bronchoscopy (ENB) and endobronchial ultrasound (EBUS) thereby encouraging in the market growth.

Threat:

Risk of complications

Healthcare institutions and providers may face legal and liability issues as a result of complications following bronchoscopy operations. The adherence to stringent standards of care and protocols by healthcare practitioners is necessary in order to mitigate difficulties and prevent potential lawsuits. This adds to the intricacy and caution associated with executing these treatments. Instances of problems might draw regulatory attention, leading authorities to enforce more stringent policies or quality control processes for bronchoscopy operations. To remain compliant, healthcare institutions could have to show that they are following strict guidelines, which might have an impact on how well they operate and how they use their resources impeding the growth of the market.

Covid-19 Impact

Healthcare personnel are more vulnerable to infection during bronchoscopy procedures because of their aerosol-generating nature. Consequently, steps have been taken to lower the possibility of viral transmission, including the use of disposable bronchoscopes, pre-bronchoscopy PCR testing, and personal protective equipment. The availability and demand for bronchoscopy services and equipment have been impacted by these changes in practice. However, because bronchoscopy has a considerable risk of infection, its usefulness in diagnosing COVID-19 is still up for discussion. To determine the pandemic's long-term effects on the bronchoscopy market, more investigation is required.

The bronchoscopes segment is expected to be the largest during the forecast period

The bronchoscopes segment is estimated to have a lucrative growth, because advanced bronchoscopes provide a broad spectrum of interventional treatments, including biopsies, ablative methods, therapeutic interventions, foreign body removal, and stent installation. The market demand for bronchoscopes has increased due to its versatility in conducting both therapeutic and diagnostic treatments. Industry innovation has been spurred by manufacturers' increased competitiveness to create and market more sophisticated bronchoscopes thus businesses work hard to launch new accessories, features, and technology in an effort to expand their market share through improved and differentiated products.

The bronchial diagnosis segment is expected to have the highest CAGR during the forecast period

The bronchial diagnosis segment is anticipated to witness the highest CAGR growth during the forecast period, in order to provide individualized and targeted therapies, such as surgery, chemotherapy, radiation, or targeted therapies; it assists doctors in identifying the stage, type, and features of lung illnesses. Healthcare professionals are increasingly depending on bronchoscopy for precise and timely diagnosis of respiratory disorders, which is driving the demand for bronchial diagnostic procedures and the bronchoscopy market.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to factors like the rising incidence of cancer in the nation, the growing popularity of minimally invasive procedures. Moreover, the market is being driven by the fact that notable developments in medical imaging technology have made targeted cancer therapy possible and enabled interventional oncologists to incorporate image-guided treatments into routine clinical practice. In addition, statistics released by the Canadian Cancer Society in November 2022 predicted that 233,900 Canadians will receive a cancer diagnosis that year. The need of cancer prevention is highlighted by this increase in incidence, which is mostly attributable to Canada's aging and expanding population.

Region with highest CAGR:

Asia-Pacific is projected to have the highest CAGR over the forecast period, owing to government's initiatives to increase funding for cancer treatments, the commercialization of cutting-edge procedures and products and the supportive regulations surrounding their development, rising healthcare spending, and the expansion of research bases in nations such as China, Japan, and India. Additionally the promising reimbursement systems and regulatory frameworks in several nations have facilitated the uptake of bronchoscopy operations encourage the growth of the market in this region.

Key players in the market

Some of the key players profiled in the Bronchoscopy Market include Boston Scientific, Cook Medical, Ethicon.Inc, Fujifilm Holdings Corporation, Olympus Corporation, Richard Wolf GmbH, Roper Technologies, Teleflex Incorporated., Medtronic, Lymol Medical, Hoya Corporation, Karl Storz, AMBU A/S, Conmed Corporation, Broncus Medical Inc., Novatech SA and Pentax Medical

Key Developments:

In November 2023, Boston Scientific Corporation announced the close of its acquisition of Relievant Medsystems Inc., a company that only U.S. Food and Drug Administration-cleared Intracept(R) Intraosseous Nerve Ablation System, a therapy to treat vertebrogenic pain that is a form of chronic low back pain.

In November 2023, Medtronic plc announced that the United States Food and Drug Administration (FDA) has approved the Symplicity Spyral(TM) renal denervation (RDN) system, also known as the Symplicity(TM) blood pressure procedure, for the treatment of hypertension.

In September 2023, Boston Scientific announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., that has developed and commercialized the Intracept(R) Intraosseous Nerve Ablation System to treat vertebrogenic pain, a form of chronic low back pain.

Product Types Covered:

  • Bronchoscopes

Components Covered:

  • Imaging Systems
  • Accessories
  • Other Components

Usages Covered:

  • Disposable
  • Reusable

Applications Covered:

  • Bronchial Treatment
  • Bronchial Diagnosis

End Users Covered:

  • Hospitals
  • Ambulatory Surgery Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bronchoscopy Market, By Product Type

  • 5.1 Introduction
  • 5.2 Bronchoscopes
    • 5.2.1 Rigid
    • 5.2.2 Flexible
    • 5.2.3 Endobronchial Ultrasound (EBUS)

6 Global Bronchoscopy Market, By Component

  • 6.1 Introduction
  • 6.2 Imaging Systems
    • 6.2.1 Light Sources
    • 6.2.2 Video Processors
    • 6.2.3 Camera Heads
    • 6.2.4 Wireless Displays & Monitors
  • 6.3 Accessories
    • 6.3.1 Mouthpieces
    • 6.3.2 Cleaning Brushes
    • 6.3.3 Biopsy Valves
    • 6.3.4 Transbronchial Aspiration Needles
    • 6.3.5 Cytology Brushes
    • 6.3.6 Biopsy Forceps
    • 6.3.7 Other Accessories
  • 6.4 Other Components

7 Global Bronchoscopy Market, By Usage

  • 7.1 Introduction
  • 7.2 Disposable
  • 7.3 Reusable

8 Global Bronchoscopy Market, By Application

  • 8.1 Introduction
  • 8.2 Bronchial Treatment
  • 8.3 Bronchial Diagnosis

9 Global Bronchoscopy Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Ambulatory Surgery Centers
  • 9.4 Other End Users

10 Global Bronchoscopy Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Boston Scientific
  • 12.2 Cook Medical
  • 12.3 Ethicon.Inc
  • 12.4 Fujifilm Holdings Corporation
  • 12.5 Olympus Corporation
  • 12.6 Richard Wolf GmbH
  • 12.7 Roper Technologies
  • 12.8 Teleflex Incorporated.
  • 12.9 Medtronic
  • 12.10 Lymol Medical
  • 12.11 Hoya Corporation
  • 12.12 Karl Storz
  • 12.13 AMBU A/S
  • 12.14 Conmed Corporation
  • 12.15 Broncus Medical Inc.
  • 12.16 Novatech SA
  • 12.17 Pentax Medical

List of Tables

  • Table 1 Global Bronchoscopy Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Bronchoscopy Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Bronchoscopy Market Outlook, By Bronchoscopes (2023-2034) ($MN)
  • Table 4 Global Bronchoscopy Market Outlook, By Rigid (2023-2034) ($MN)
  • Table 5 Global Bronchoscopy Market Outlook, By Flexible (2023-2034) ($MN)
  • Table 6 Global Bronchoscopy Market Outlook, By Endobronchial Ultrasound (EBUS) (2023-2034) ($MN)
  • Table 7 Global Bronchoscopy Market Outlook, By Component (2023-2034) ($MN)
  • Table 8 Global Bronchoscopy Market Outlook, By Imaging Systems (2023-2034) ($MN)
  • Table 9 Global Bronchoscopy Market Outlook, By Light Sources (2023-2034) ($MN)
  • Table 10 Global Bronchoscopy Market Outlook, By Video Processors (2023-2034) ($MN)
  • Table 11 Global Bronchoscopy Market Outlook, By Camera Heads (2023-2034) ($MN)
  • Table 12 Global Bronchoscopy Market Outlook, By Wireless Displays & Monitors (2023-2034) ($MN)
  • Table 13 Global Bronchoscopy Market Outlook, By Accessories (2023-2034) ($MN)
  • Table 14 Global Bronchoscopy Market Outlook, By Mouthpieces (2023-2034) ($MN)
  • Table 15 Global Bronchoscopy Market Outlook, By Cleaning Brushes (2023-2034) ($MN)
  • Table 16 Global Bronchoscopy Market Outlook, By Biopsy Valves (2023-2034) ($MN)
  • Table 17 Global Bronchoscopy Market Outlook, By Transbronchial Aspiration Needles (2023-2034) ($MN)
  • Table 18 Global Bronchoscopy Market Outlook, By Cytology Brushes (2023-2034) ($MN)
  • Table 19 Global Bronchoscopy Market Outlook, By Biopsy Forceps (2023-2034) ($MN)
  • Table 20 Global Bronchoscopy Market Outlook, By Other Accessories (2023-2034) ($MN)
  • Table 21 Global Bronchoscopy Market Outlook, By Other Components (2023-2034) ($MN)
  • Table 22 Global Bronchoscopy Market Outlook, By Usage (2023-2034) ($MN)
  • Table 23 Global Bronchoscopy Market Outlook, By Disposable (2023-2034) ($MN)
  • Table 24 Global Bronchoscopy Market Outlook, By Reusable (2023-2034) ($MN)
  • Table 25 Global Bronchoscopy Market Outlook, By Application (2023-2034) ($MN)
  • Table 26 Global Bronchoscopy Market Outlook, By Bronchial Treatment (2023-2034) ($MN)
  • Table 27 Global Bronchoscopy Market Outlook, By Bronchial Diagnosis (2023-2034) ($MN)
  • Table 28 Global Bronchoscopy Market Outlook, By End User (2023-2034) ($MN)
  • Table 29 Global Bronchoscopy Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 30 Global Bronchoscopy Market Outlook, By Ambulatory Surgery Centers (2023-2034) ($MN)
  • Table 31 Global Bronchoscopy Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.